| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $128K | — | -78.6% |
| Cost of Revenue | $7.2M | — | -18.1% |
| Gross Profit | -$7.0M | — | +13.6% |
| R&D Expense | $2.6M | — | +5.9% |
| SG&A Expense | $3.9M | — | -30.7% |
| Operating Income | -$13.8M | — | +24.1% |
| Income Tax | $0 | — | — |
| Net Income | -$15.9M | — | +11.7% |
| EPS (Basic) | -$0.54 | — | +64.0% |
| EPS (Diluted) | -$0.54 | — | +64.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.5M | +7.0% | +83.9% |
| Accounts Receivable | $37K | +184.6% | -85.4% |
| Inventory | $123K | -12.1% | -98.2% |
| Current Assets | $24.8M | -5.6% | +4.6% |
| Total Assets | $48.6M | -5.1% | -9.3% |
| Current Liabilities | $23.0M | -9.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.5M | — | +26.2% |
| Capital Expenditures | $930K | — | +22.0% |
| Investing Cash Flow | $725K | — | -94.5% |
| Financing Cash Flow | $14.0M | — | — |
| Free Cash Flow | -$14.4M | — | +24.3% |
| +3.4% |
| Total Liabilities | $39.1M | -8.1% | -5.7% |
| Stockholders' Equity | $9.4M | +9.6% | -21.8% |